APA (7th ed.) Citation

Moldovan, D., Reshef, A., Fabiani, J., Kivity, S., Toubi, E., Shlesinger, M., . . . Cicardi, M. (2012). Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Clinical & Experimental Allergy, 42(6), 929. https://doi.org/10.1111/j.1365-2222.2012.03984.x

Chicago Style (17th ed.) Citation

Moldovan, D., et al. "Efficacy and Safety of Recombinant Human C1-inhibitor for the Treatment of Attacks of Hereditary Angioedema: European Open-label Extension Study." Clinical & Experimental Allergy 42, no. 6 (2012): 929. https://doi.org/10.1111/j.1365-2222.2012.03984.x.

MLA (9th ed.) Citation

Moldovan, D., et al. "Efficacy and Safety of Recombinant Human C1-inhibitor for the Treatment of Attacks of Hereditary Angioedema: European Open-label Extension Study." Clinical & Experimental Allergy, vol. 42, no. 6, 2012, p. 929, https://doi.org/10.1111/j.1365-2222.2012.03984.x.